Neuropsychiatric symptoms: Risk factor or disease marker? A study of structural imaging biomarkers of Alzheimer's disease and incident cognitive decline
Human Brain Mapping · 2024-09 · 45 (13)
DOI: 10.1002/hbm.70016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Brain Mapping, online erschienen am 10.09.2024. Verfasst von Dylan X Guan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Science Education, University of Calgary, Calgary, Alberta, Canada. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction, Magnetic Resonance Imaging. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Neuropsychiatric symptoms (NPS) are risk factors for Alzheimer's disease (AD) but can also manifest secondary to AD pathology. Mild behavioral impairment (MBI) refers to later‐life emergent and persistent NPS that may mark early‐stage AD. To distinguish MBI from NPS that are transient or which represent psychiatric conditions (non‐MBI NPS), we investigated the effect of applying MBI criteria on NPS associations with AD structural imaging biomarkers and incident cognitive decline. Data for participants ( n = 1273) with normal cognition (NC) or mild cognitive impairment (MCI) in the National Alzheimer's Coordinating Center Uniform Data Set were analyzed. NPS status (MBI, non‐MBI NPS) was derived from the Neuropsychiatric Inventory Questionnaire and psychiatric history. Normalized measures of bilateral hippocampal (HPC) and entorhinal cortex (EC) volume, and AD meta‐region of interest (ROI) mean cortical thickness were acquired from T1‐weighted magnetic resonance imaging scans. Multivariable linear and Cox regressions examined NPS associations with imaging biomarkers and incident cognitive decline, respectively. MBI was associated with lower volume and cortical thickness in all ROIs in both NC and MCI, except for EC volume in NC. Non‐MBI NPS were only associated with lower HPC volume in NC. Although both of the NPS groups showed higher hazards for MCI/dementia than No NPS, MBI participants showed more rapid decline. Although both types of NPS were linked to HPC atrophy, only NPS that emerged and persisted in later‐life, consistent with MBI criteria, were related to AD neurodegenerative patterns beyond the HPC. Moreover, MBI predicted faster progression to dementia than non‐MBI NPS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Science Education, University of Calgary, Calgary, Alberta, Canada.
- Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
- Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
- Quebec Heart and Lung Institute, Québec City, Quebec, Canada.
- Department of Radiology, Université Laval, Québec City, Quebec, Canada.
- Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
ORCID-Profile: Dylan X Guan
Förderung
- NIA NIH HHS
Zitieren
APA
Guan, D. X., Rehman, T., Nathan, S., Durrani, R., Potvin, O., Duchesne, S., Pike, G. B., Smith, E. E., & Ismail, Z. (2024). Neuropsychiatric symptoms: Risk factor or disease marker? A study of structural imaging biomarkers of Alzheimer's disease and incident cognitive decline. Human Brain Mapping, 45(13). https://doi.org/10.1002/hbm.70016
Vancouver
Guan DX, Rehman T, Nathan S, Durrani R, Potvin O, Duchesne S, et al. Neuropsychiatric symptoms: Risk factor or disease marker? A study of structural imaging biomarkers of Alzheimer's disease and incident cognitive decline. Human Brain Mapping. 2024;45(13). doi:10.1002/hbm.70016
BibTeX
@article{Guan2024,
author = {Guan, Dylan X and Rehman, Tanaeem and Nathan, Santhosh and Durrani, Romella and Potvin, Olivier and Duchesne, Simon and Pike, G Bruce and Smith, Eric E and Ismail, Zahinoor},
title = {Neuropsychiatric symptoms: Risk factor or disease marker? A study of structural imaging biomarkers of Alzheimer's disease and incident cognitive decline},
journal = {Human Brain Mapping},
year = {2024},
volume = {45},
number = {13},
doi = {10.1002/hbm.70016}
}
EUVIMED